Back to results
US 7,842,693 B2Granted
Substituted piperazines
AssigneeChemoCentryx, Inc.
InventorsAndrew M. K. Pennell, James B. Aggen, J. J. Kim Wright, Subhabrata Sen, Brian E. McMaster, Daniel Joseph Dairaghi, Valeri V. Martichonok
Life of this patent
Estimating the term…
Abstract
Compounds are provided that act as potent antagonists of the CCR1 receptor, and which have been further confirmed in animal testing for inflammation, one of the hallmark disease states for CCR1. The compounds are generally aryl piperazine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.
Claims23
A compound having the formula:
- wherein the subscript m is 0 to 1;
- R1 is C1-4 alkyl;
- R2a, R2b, R2c, R2d and R2e are each members independently selected from the group consisting of hydrogen, halogen, —ORc, —NRcRd, —SRc, —Re, —CN, —NO2, —CO2Rc, —CONRcRd, —C(O)Rc, —OC(O)NRcRd, —NRdC(O)Rc, —NRdC(O)2Re, —NRc—C(O)NRcRd, —S(O)Re, —S(O)Re, —NRcS(O)2Re, —S(O)2NRcRd, —N3, —X2ORc, —O—X2ORc, —X2NRcRd, —O—X2NRcRd, wherein X2 is C1-4 alkylene, and each Rc and Rd is independently selected from hydrogen, C1-8 alkyl, C1-8 haloalkyl, and C3-6 cycloalkyl, or optionally Rc and Rd when attached to the same nitrogen atom can be combined with the nitrogen atom to form a five or six-membered ring having from 0 to 1 additional heteroatoms selected from N and O as ring members;
- and each Re is independently selected from the group consisting of C1-8 alkyl, C1-8 haloalkyl, and C3-6 cycloalkyl, such that at least one of R2a, R2b, R2c, R2d and R2e is other than H;
- R3a, R3b and R3c are each members independently selected from the group consisting of hydrogen, halogen, —ORf, —NRfRg, —SRf, —Rh, —CN, —NO2, —CO2Rf, —CONRfRg, —C(O)Rf, —X3ORf, —X3OC(O)Rf, —X3NRfRg, —X3SRf, —X3CN, —X3NO2, —X3CO2Rf, —X3CONRfRg, —X3C(O)Rf, —X3NRgC(O)Rf, —X3NRgC(O)2Rh, —X3NRf—C(O)NRfRg, —Y, —X3Y, and —X3N3, wherein Y is selected from the group consisting of furanyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, pyrazolyl, imidazolyl, thiazolyl, oxazolyl, isoxazolyl, isothiazolyl, triazolyl, tetrazolyl and oxadiazolyl, optionally substituted with from one to three substituents selected from the group consisting of halogen, —ORf, and —Rh, and wherein each X3 is independently C1-4 alkylene, and each Rf and Rg is independently selected from hydrogen, C1-8 alkyl, C1-8 haloalkyl, and C3-6 cycloalkyl, or when attached to the same nitrogen atom can be combined with the nitrogen atom to form a five or six-membered ring having from 0 to 1 additional heteroatoms selected from N and O as ring members, and each Rh is independently selected from the group consisting of C1-8 alkyl, C1-8 haloalkyl, and C3-6 cycloalkyl, wherein at least one of R3a, R3b and R3c is selected from the group consisting of —Y and —X3—Y, and wherein at least one of R3a, R3b and R3c is selected from the group consisting of halogen, C1-4alkyl and C1-4haloalkyl.
2 more elements
Dependencies are inferred from the claim text.